BoelaertJ.R., FenvesA.Z., CoburnJ.W.Deferoxamine therapy and mucormycosis in dialysis patients: report of an international registry. Am Kidney Dis.1991; 18: 660–667.
2.
BrownA.E., CicognaC., ArmstrongD.Mucormycosis in patients with cancer. Infect Med.1994; 11: 562–563.
3.
Mucormycosis.Ann Intern Med.1980; 93: 93–108.
4.
DalyA.L., VelazquezL.A., BradleyS.F.Mucormycosis: association with deferoxamine therapy. Am J Med.1989; 87: 468–471.
5.
EiserA.R., SlifkinR.F., NeffM.S.Intestinal mucormycosis in hemodialysis patients following deferoxamine. Am Kidney Dis.1987; 10: 71–73.
6.
HamdyN.A., AndrewS.M., ShortlandJ.R.Fatal cardiac zygomycosis in a renal transplant patient treated with deferoxamine. Nephrol Dial Transplant.1989; 4: 911–913.
7.
BernsJ.S., LedermanM.M., GreeneB.M.Nonsurgical cure of pulmonary mucormycosis. Am J Med Sci.1984; 287: 42–44.
8.
BoelaertJ.R., Van CutsemJ., de LochtM.Deferoxamine augments growth and pathogenicity of Rhizopus, while hydroxypyridinone chelators have no effect. Kidney Int.1994; 45: 667–671.
